13F HOLDINGS REPORT
Flagship Pioneering Inc.
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000950123-24-008727
Total Value
$843.4M
Positions
12
Other Managers
3
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 4,628,225 | $549.6M | 65.17% |
| 2 | Sana Biotechnology Inc | SANA | 15,909,178 | $86.9M | 10.30% |
| 3 | Foghorn Therapeutics Inc | FHTX | 9,330,878 | $53.7M | 6.36% |
| 4 | Sana Biotechnology Inc | SANA | 9,092,678 | $49.6M | 5.89% |
| 5 | Omega Therapeutics Inc | 68217N105 | 22,240,723 | $46.0M | 5.46% |
| 6 | Foghorn Therapeutics Inc | FHTX | 3,343,242 | $19.2M | 2.28% |
| 7 | Omega Therapeutics Inc | 68217N105 | 6,984,856 | $14.5M | 1.71% |
| 8 | Seres Therapeutics Inc | MCRB | 14,664,169 | $10.6M | 1.26% |
| 9 | Seres Therapeutics Inc | MCRB | 8,452,876 | $6.1M | 0.73% |
| 10 | Syros Pharmaceuticals Inc | 87184Q206 | 1,000,000 | $5.2M | 0.61% |
| 11 | Syros Pharmaceuticals Inc | 87184Q206 | 293,849 | $1.5M | 0.18% |
| 12 | Moderna Inc | MRNA | 3,924 | $465,975 | 0.06% |